Using MRI images and physical calculations, team led by Hebrew University PhD student gains vital data previously available only via autopsy or tissue sample examinations

Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers

Senior analyst Haviv Rettig Gur on today's parade through the Muslim Quarter and the ultra-Orthodox budget; health reporter Renee Ghert-Zand with cancer and Alzheimer's innovations

Research done at Hebrew University could lead to better understanding of genetic origins of the disease, as well as treatments to prevent or slow cognitive deterioration

Weizmann Institute neuroimmunologist bucked convention to prove that brain is not isolated from immune system, leading to possible therapies to treat Alzheimer's and other diseases

Bacteria living in our digestive tracts remain hungry for critical nutrients missing in the American diet

Tzohar and Emda organizations team up to provide practical guidance on how to follow Jewish law while including the ill in holiday traditions as best as possible

Effectiveness shown via behavior tests and brain analysis, say authors of research; they stress it's a small sample and progress to human drug, if successful, will take time

US, Japanese drugmakers announce results of full study, but remains unclear how much of a difference it may make to lives of those affected by the condition

Psychologists say average person can learn from and use methods employed by professionals in tough and demanding fields